 |
|
adenoviral vector encoding HSV thymidine kinase
An adenoviral vector engineered to express the herpes simplex virus thymidine kinase (HSV-tk) gene, which, when administered in conjunction with a synthetic acyclic guanosine analogue, possesses potential antineoplastic activity. Adenoviral vector encoding HSV thymidine kinase is transduced into tumor cells, sensitizing tumor cells that overexpress HSV-tk to synthetic acyclic guanosine analogues. Subsequently, a low dose of a synthetic acyclic guanosine analogue such as valacyclovir (VCV) or ganciclovir (GCV) is given, which may preferentially kill tumor cells containing the adenoviral vector and overexpressing HSV-tk. Release of tumor-associated antigens (TAAs) by dying tumor cells may then stimulate an antitumor cytotoxic T lymphocyte (CTL) response. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | adenoviral vector encoding herpes simplex virus thymidine kinase | | | | Abbreviations: | | Ad HSV-tk
adeno-HSV-tk
ADV-tk | | |
| Previous: | Adanon, Adderall, Adderall XR, adefovir dipivoxil, adenovector encoding MDA7 | | Next: | adenovirus 5-tumor necrosis factor alpha, adenovirus B7-1, adenovirus encoding human aquaporin-1, adenovirus encoding recombinant human endostatin, adenovirus HER2-transduced autologous dendritic cell vaccine |
|
|
